←
Pascal Devant412 posts
Pascal Devant avatar

Pascal Devant

@pascal_devant

Postdoc @Marsonlab @GladstoneInst @UCSF | PhD in Virology with @jkagan1 @harvardmed | Interest in Mechanistic Immunology, Cell Biology, Synthetic Biology

◷ Joined July 2021▧ 32 Photos and videos
Pascal Devant avatar
Pascal Devant@pascal_devant·Aug 17

The final version of my first postdoc paper is out today in @NatureBiotech! nature.com/articles/s41587-0… Together with @HyuncheolJung @jccarnevale we established a virus-like particle toolkit for genetic engineering and pooled CRISPR screening in primary human myeloid cells 🧬

Bryson Lab avatar
⟳ Pascal Devant retweeted
Bryson Lab@TheBrysonLab·Oct 23

Antigen discovery and TB vax friends 🧵 We set out to find more Mtb peptides presented on MHC-I. We had a strong biological prior, a high-throughput binding screen, and a very sensitive targeted MS assay. Of 286 candidates, we detected 2. biorxiv.org/content/10.64898…

Ronghui (Ron) Zhu avatar
⟳ Pascal Devant retweeted
Ronghui (Ron) Zhu@RonZhu2015·Sep 3

Thrilled to share that our work on genome-scale perturb-seq in primary human T cells is now published in Cell (cell.com/cell/fulltext/S0092…) 🎉. The original post summarized most key results ⬇️ with a few key updates:

Together with Emma Dann, we are thrilled to present a massive new Perturb-seq atlas of 22M primary CD4+ T cells, from 4 donors, across 3 timepoints – the result of a decade-long collaboration between the Marson (@MarsonLab) and Pritchard (@jkpritch) labs. 🧵👇

Post attachment
Jonathan Kagan avatar
⟳ Pascal Devant retweeted
Jonathan Kagan@jkagan1·Sep 2

Change the textbooks. Trans-splicing as a means to diversify the proteome. Many congrats to Ruaidhri Jackson and Olivia Venezia on this remarkable discovery. nature.com/articles/s41586-0…

Gladstone Institutes avatar
⟳ Pascal Devant retweeted
Gladstone Institutes@GladstoneInst·Aug 18

🚨 NEW PUBLICATION 🚨 "Virus-like particles enable targeted gene engineering and pooled #CRISPR screening in primary human myeloid cells" @UCSF @jccarnevale @NatureBiotech go.nature.com/4gbVKJS

Gladstone Institutes avatar
⟳ Pascal Devant retweeted
Gladstone Institutes@GladstoneInst·Aug 17

Scientists at Gladstone and @UCSF developed a method to genetically edit myeloid cells, immune cells that act as the body’s first responders. @NatureBiotech @jccarnevale bit.ly/3SGx5Fw

Pascal Devant avatar
Pascal Devant@pascal_devant·Aug 17

KO of A20 drove a proinflammatory state resistant to suppressive repolarization and enhanced cytotoxicity in HER2-CAR macrophages. With TNFAIP3 surfacing as a brake on antitumor function now in both T cells and macrophages, it may be an attractive target for cell therapies.

Post attachment
Pascal Devant avatar
Pascal Devant@pascal_devant·Aug 17

Our screens converged on the gene TNFAIP3, which codes for the protein A20, as a master regulator of macrophage inflammatory polarization.

Post attachment
Pascal Devant avatar
Pascal Devant@pascal_devant·Aug 17

To make pooled screening possible we developed SLICeVLP, sgRNA delivery by lentivirus with Cas9 delivery by eVLPs. We used it for pooled loss-of-function screens and Perturb-seq in primary human macrophages, identifying regulators of inflammatory signaling.

Post attachment
Pascal Devant avatar
Pascal Devant@pascal_devant·Aug 17

This platform supports knockout, base editing, and epigenetic silencing, and paired with AAV donor delivery it enables site-specific integration of large sequences by homology-directed repair, even in these post-mitotic cells.

Post attachment
Pascal Devant avatar
Pascal Devant@pascal_devant·Aug 17

@HyuncheolJung and I adapted these VLP-based methods to deliver CRISPR ribonucleoproteins to primary human monocytes, macrophages, and dendritic cells at high efficiency while preserving both viability and innate immune responsiveness.

Post attachment
Pascal Devant avatar
Pascal Devant@pascal_devant·Aug 17

When looking for alternative delivery methods for CRISPR gene editing cargos, we came across virus-like particle (VLP) that @davidrliu and @DoudnaJennifer's labs have developed recently. nature.com/articles/s41587-0… nature.com/articles/s41587-0…

Pascal Devant avatar
Pascal Devant@pascal_devant·Aug 17

Primary human myeloid cells in particular have been largely inaccessible to functional genomics, hampered by cell loss and functional impairment upon nucleofection, meaning pooled screening approaches that reshaped T cell biology have not been available in macrophages and DCs.